8-K: AYRO Secures $7M, Extends Debt Maturity to 2027
Securities Offering
AYRO, Inc. completed a $7 million preferred stock offering and amended terms of its existing Series H-7 preferred stock, extending its maturity to February 2027.
Summary
- AYRO, Inc. issued 7,000 shares of newly-designated Series I Convertible Preferred Stock at a stated value of $1,000 per share, totaling $7 million.
- The Series I Preferred Stock is initially convertible into up to 875,000 shares of common stock at an initial conversion price of $8.00 per share.
- Warrants to acquire up to 875,000 shares of common stock at an exercise price of $8.00 per share were also issued alongside the Series I Preferred Stock.
- The Series I Preferred Stock carries a 7.0% annual dividend rate, which increases to 15.0% per annum upon the occurrence of a Triggering Event.
- The company amended its Series H-7 Preferred Stock terms, extending its maturity date to February 4, 2027, and revising dividend and installment payment schedules.
- The amendments to the Series H-7 Preferred Stock also modified the definition of 'Excluded Securities' and adjusted the installment schedule amount to 1,222.22 preferred shares.
Sentiment
Score: 3
Explanation: While the company successfully raised capital, the terms of the preferred stock, including a high dividend rate, significant potential dilution, and restrictive covenants, suggest a challenging financing environment and could be detrimental to existing common shareholders. The extension of existing preferred stock maturity also points to ongoing financial management needs.
Positives
- Secured $7 million in new capital through the Series I Preferred Stock offering, providing funding for operations or strategic initiatives.
- Extended the maturity date of the Series H-7 Preferred Stock to February 4, 2027, which provides additional financial flexibility by deferring repayment obligations.
Negatives
- The issuance of Series I Preferred Stock and associated warrants could lead to significant dilution for existing common shareholders, with potential for up to 1,750,000 additional common shares if fully converted/exercised.
- The Series I Preferred Stock carries a 7.0% annual dividend rate, representing a recurring cash obligation for the company.
- A default dividend rate of 15.0% per annum applies if a Triggering Event occurs, significantly increasing the cost of capital.
- Redemption premiums of 125% to 130% apply upon Triggering Events or a Change of Control, potentially leading to substantial cash outflows for the company.
- Restrictive covenants, such as maintaining a cash minimum of 50% of the aggregate Stated Value of outstanding Preferred Shares, could limit the company's operational and financial flexibility.
Risks
- Significant potential for dilution of common stock from the conversion of Series I Preferred Stock and exercise of warrants, as well as existing Series H-7 Preferred Stock.
- Failure to maintain the required cash minimum (50% of aggregate Stated Value of Preferred Shares outstanding) or other financial covenants could trigger a Triggering Event, leading to mandatory redemption at a premium.
- Various Triggering Events, including trading suspension, failure to deliver shares, insufficient authorized shares, failure to pay dividends/amounts due, or significant indebtedness defaults ($250,000+), could result in mandatory redemption at a premium.
- In a liquidation event, Series I Preferred Stockholders are entitled to a preferential payment (greater of 125% of Conversion Amount or as-converted value) before common stockholders receive any distribution, and junior to Series H-7 Preferred Stock.
- The company may need stockholder approval to issue shares beyond the Nasdaq Exchange Cap, and failure to obtain it could result in cash payments in lieu of shares, potentially straining liquidity.
- The requirement for consent from a majority of Preferred Holders for certain corporate actions (e.g., amending preferred stock rights, creating senior/pari passu stock, certain junior stock redemptions) could limit management's strategic flexibility.
Future Outlook
The filing does not provide specific forward-looking statements or guidance regarding the company's operational or financial performance, focusing instead on the terms and conditions of the securities offering and amendments.
Industry Context
This filing is company-specific, detailing a securities offering and amendments to existing preferred stock terms. It does not provide broader industry context or trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| New Securities Designation | Creation of Series I Convertible Preferred Stock with specific rights, preferences, and limitations, impacting the company's capital structure. | August 6, 2025 | Introduces a new class of preferred stock with senior rights to common stock, affecting the hierarchy of claims on company assets and earnings. |
| Amendment to Existing Securities | Amendment of the Certificate of Designations for Series H-7 Convertible Preferred Stock, modifying its maturity date, dividend payment dates, installment amounts, and definition of 'Excluded Securities'. | August 6, 2025 | Adjusts the terms of existing preferred stock, potentially altering the company's financial obligations and the rights of Series H-7 holders. |
Stakeholder Impact
- **Shareholders (Common)**: Face potential significant dilution from the conversion of Series I Preferred Stock and exercise of warrants. Their claims are subordinated to both Series I and Series H-7 Preferred Stockholders in liquidation.
- **Preferred Stockholders (Series I & H-7)**: Gain enhanced rights, including liquidation preference, fixed dividend payments, and anti-dilution protection. They also have the ability to demand redemption upon certain Triggering Events.
- **Company (Management/Operations)**: Benefits from the influx of $7 million in capital but is subject to restrictive covenants (e.g., cash minimum, limits on indebtedness, asset transfers) and ongoing dividend obligations, which could constrain operational flexibility.
Next Steps
- The company must ensure sufficient authorized common stock is reserved (at least 200% of the Required Reserve Amount) for the conversion of preferred shares.
- If an Authorized Share Failure occurs, the company is required to hold a stockholder meeting within 60 days to approve an increase in authorized common shares.
- The company must comply with various covenants, including maintaining specified cash minimums, adhering to limits on indebtedness, restricting certain asset transfers, and making timely dividend and installment payments on both Series I and Series H-7 Preferred Stock.
Key Dates
| Date | Description |
|---|---|
| August 7, 2023 | Company entered into the Securities Purchase Agreement for Series H-7 Preferred Stock. |
| February 7, 2024 | First Installment Date for Series H-7 Preferred Stock (subject to change by Buyer notice or mutual agreement). |
| May 7, 2024 | Optional Installment Date for Series H-7 Preferred Stock. |
| August 7, 2024 | Optional Installment Date for Series H-7 Preferred Stock. |
| November 7, 2024 | Optional Installment Date for Series H-7 Preferred Stock. |
| December 2, 2024 | Date of Restricted Stock and Cash-Settled Restricted Stock Unit Award Agreements for directors. |
| February 7, 2025 | Optional Installment Date for Series H-7 Preferred Stock. |
| July 25, 2025 | Board of Directors adopted resolution to create Series I Convertible Preferred Stock. |
| July 31, 2025 | Board declared dividends of Series A Junior Participating Preferred Stock purchase rights. |
| August 1, 2025 | Installment Date for Series H-7 Preferred Stock. |
| August 4, 2025 | Company entered into the Series I Purchase Agreement and the Omnibus Waiver, Consent, Notice and Amendment Agreement for Series H-7 (Subscription Date for Series I). |
| August 5, 2025 | Previous Current Report on Form 8-K filed with the SEC. |
| August 6, 2025 | Company filed the Certificate of Designations of Series I Preferred Stock and the Certificate of Amendment to Series H-7 Preferred Stock with the Secretary of State of Delaware (Date of earliest event reported). |
| August 11, 2025 | Record date for Series A Junior Participating Preferred Stock purchase rights. |
| August 12, 2025 | Date of signing of the Current Report on Form 8-K. |
| November 4, 2025 | Equity Award Restriction Date for Series I Preferred Stock, after which a 10% limit on stock plan issuances applies. Also, the end date for a temporary waiver of a 2% limit on stock plan issuances for Series H-7. |
| November 30, 2025 | Installment Date for Series I and Series H-7 Preferred Stock. |
| February 4, 2027 | Maturity Date for Series I Preferred Stock and the extended Maturity Date for Series H-7 Preferred Stock. |
Recommendation
sellThe terms of the Series I Preferred Stock offering, including a high dividend rate (7.0% escalating to 15.0%), significant potential dilution from conversion at an $8.00 price, and substantial redemption premiums (125-130%), are highly unfavorable for existing common shareholders. The restrictive covenants, such as the 50% cash minimum, further limit the company's financial flexibility. While the capital raise provides immediate liquidity, the onerous terms suggest a distressed financing situation, indicating underlying financial weakness and a high cost of capital that will likely erode shareholder value over time. The extension of the Series H-7 maturity, while deferring immediate obligations, reinforces the reliance on preferred equity with unfavorable terms. These factors collectively point to a deteriorating outlook for common equity.
Keywords
AYRO, Preferred Stock, Convertible Preferred Stock, Series I, Series H-7, Warrants, Capital Raise, SEC Filing, 8-K, Dilution, Corporate Governance, Debt Extension, Nasdaq
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.